Protein Chip Witnesses Greater Adoption in Clinical Research, and Drug Discovery
Protein chip, technically a protein microarray method, has been a promising high-throughput approach used in disease rate monitoring, and clinical diagnostics. While it has become a vital tool for use in large-scale biology experiments over the past couple of decades, considerably high demand is expected to come in from clinical research, diagnostics, and drug discovery segments. Rampantly growing prevalence of cancers is expected to remain an important driver behind surging adoption of protein chip by researchers. The top barrier to rising life expectancy worldwide, cancer remains the leading mortality cause behind roughly 10 million deaths across the globe in 2020.
Moreover, there was an estimated 19+ million new cancer cases the same year, according to the World Health Organization (WHO) statistics. The recent past has witnessed development of the various efficient, reliable, and advanced diagnostic technologies, which is also a strong factor driving protein chip demand. As protein chips enable faster, easier, and parallel tracking of a large number of addressable protein-protein interactions, small molecule targets, protein–phospholipid interactions, and substrates of proteins kinases, protein microarray will remain a preferred tool in the world of molecular biology, and biochemistry. With personalised medicine firming up, protein chip technique will also most likely take off.
Proteomics Key Revenue Generator; Diagnostics Promises Substantial Protein Chip Adoption
Proteomics, a significant revenue generator for the protein chip market by 2019, continues to find application in drug discovery, as well as biomedical research. Continued preference for proteomics for applications like chromatography, superficial fluid chromatography, X-ray crystallography, spectroscopy, protein fractionation, surface plasmon resonance, and electrophoresis also places it ahead of other protein chip applications. Proteomics has been proven to provide a more accurate picture of the desired (in-vivo) outcome, and remains a chosen tool for effective research on disease pathogenesis, study of tumour resistance mechanisms, and therapeutic developments.
While protein functional analysis also remains a sought-after area of application, the massive opportunity emerging in the field of diagnostics points to exponential demand growth in the near future. The global COVID-19 pandemic particularly has been creating multiple windows of opportunities for protein chip market players. With growing interest around protein identification and protein-virus interactions through various tests that aid in understanding a patient’s body vitals, biotech companies are showing greater preference for protein chips. The fact that vaccination at a global will take a lot of time than was expected to, further complements the growing protein chip consumption amid pandemic.
When it comes to analysing protein chip adoption based on the underlying technology, functional protein microarray will continue to gain heavy traction for research studies in protein function areas. Analytical microarrays, and reverse phase protein microarray are also expected to remain prominent technology types – the former exhibiting decent growth in rate of adoption on account of lower costs involved, and higher throughput.
Inadequate Protein Yield of Desired Quality Continues to Challenge Market Growth
Despite exploding application potential within the field of advanced disease diagnostics, there are certain challenges that continue to play out as an obstacle decelerating the growth of the protein chip market in long run. High-quality protein production in a high-throughput fashion has been a longstanding challenge facing biotech companies. Retaining the quality of proteins for longer in order to maintain the final protein microarray quality is another factor that continues to challenge researchers as it critically requires stable microenvironment. Scarce availability of high-quality proteins on the market is thus a major deterrent to market growth. Low protein yield of desired consistency, quality, and reliability is expected to remain a long-term growth limiting factor for the protein chip market throughout the period of forecast.
North America, and Europe Remain Lucrative; Asia Pacific Exhibits High Potential
In 2019, North America maintained the lead in the global market for protein chip, closely trailed by Europe. Strong presence of top biotech companies, coupled with considerably significant funding allotted to collaborative research activities, will continue to uphold dominance of the region in global landscape. The European market, on the other hand, is expected to benefit from the rising cancer prevalence, and the subsequently growing interest around leveraging protein chip as a prime research tool. Top-notch healthcare quality, expansion of all related aspects of healthcare, and government support to molecular biology, and biotechnological research collectively account for the position of Europe as one of the top protein chip markets. Led by China, and India, the market in Asia Pacific is also projected to exhibit remarkable performance in terms of protein chip adoption, especially in the diagnostics segment. COVID-19 diagnostics has further provided an impetus to the use of protein chips in critical diagnosis.
Key Companies in Global Protein Chip Market
Some of the key companies operating in the global protein chip market include Sigma Aldrich Corporation, SEQUENOM, Inc., Biacore, EMD Millipore, Illumina, Inc., Agilent Technologies, Affymetrix, Inc., HTS Biosystems, Life Technologies Corporation, Ciphergen Biosystems, and Lumicyte.
Please Note: The above mentioned segmentation/companies/countries are likely to differ in the actual report as they are based on preliminary research.
Under uncertainty, traditional approaches to strategic planning can be downright dangerous. True ambiguity is no basis to forecast the future – degree of risk, the magnitude of circumstances, conditions and consequences are not known or unpredictable. To avoid dangerous binary views of uncertainty; strategic posture, moves and actions through market research is the best bet.Read more